glp-1 meds corona Safety Check Staying in Scope: Understanding COVID-19

Dual agonists can blunt thirst perception, and dehydration worsens side effects like constipation, fatigue, and headaches

To induce weight loss, we employed the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide and the neuropeptide Y receptor Y2 (NPY2R) agonist BI8271, which potentiates GLP-1R-mediated weight loss

GLP-1 receptors in the hypothalamus and brainstem mediate appetite suppression and increased satiety , contributing to reduced food intake and weight loss

J Am Soc Nephrology: JASN

GLP-1RA use decreased the need for rescue insulin administration, with a significant difference in the pooled effect size ( OR 0.39

7) Monitor for nutrient gaps